 |
|
D1/3-MAGE-3-His fusion protein
A recombinant fusion protein derived from the melanoma antigen MAGE-3 with potential immunostimulating and antineoplastic activities. Recognized by specific cytotoxic T lymphocytes, D1/3-MAGE-3-His fusion protein may boost antitumoral immune responses when used in a vaccine formulation. This recombinant chimeric protein is produced by fusing MAGE-3 with a lipidated protein D derived from H. influenzae at its N-terminus and a sequence of several histidine residues at its C-terminus. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | D1/3-Mage-3 Fusion Protein
D1/3-Mage-3 Fusion Protein (SB MAGE-3)
SB MAGE-3 | | | | Abbreviation: | | D1/3 MAGE3 HIS | | | | Code name: | | GSK 2132231A | | |
| Previous: | Cytomel, Cytosar-U, Cytoxan, D-cycloserine, D-methionine formulation MRX-1024 | | Next: | DAB389 epidermal growth factor, dacarbazine, dacetuzumab, daclizumab, Dacogen |
|
|
